GlassScriptPhysician profile
Sergei A Pushilin
NPI 1174884779
$5,355.71
in general payments reported to CMS, 2019-2025
13 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,353 · 2020: $298 · 2021: $3,228 · 2022: $34.30 · 2023: $69.61 · 2024: $254 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $254 · Food and Beverage: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $253.62 |
| Food and Beverage | $188.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes USA Products LLC | $3,183.66 | 2021 | |
| Skeletal Dynamics INC | $799.60 | 2019 | |
| Stryker Corporation | $552.08 | 2019-2024 | Actishield |
| Depuy Synthes Sales INC. | $379.03 | 2019-2021 | |
| Integra Lifesciences Corporation | $149.34 | 2019 | |
| Smith+Nephew, INC. | $82.88 | 2022-2025 | Trigen Intertan |
| Providence Medical Technology, INC. | $54.22 | 2025 | |
| Globus Medical, INC. | $51.17 | 2023 | Distal Femur Plate System |
| Acumed LLC | $36.52 | 2020 | |
| Biocomposites INC | $18.66 | 2019 | |
| Linvatec Corporation | $18.44 | 2023 | Biobrace 23mm |
| Musculoskeletal Transplant Foundation INC. | $16.45 | 2025 | |
| Radius Health, INC. | $13.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergei Pushilin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.